I48 I47
Conditions
Interventions
Group 1: In patients in whom invasive electroanatomical substrate mapping and catheter ablation is performed (based on a clinical indication), additional non-invasive methods for identification of arr
Sponsors
Charité Campus Charité Mitte
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: All patients in which a left atrial of ventricular electroanatomical substrate mapping is performed based on a clinical indication.
Exclusion criteria
Exclusion criteria: - Pregnancy; Gadolinium-MRI will not be performed if: GFR < 45 ml/min/1.73 m2; intolerance or allergy against Gadolinium contrast agents; application of Gadolinium contrast agents in the preceding 6 months; denial of the Patient; Echo contrast Agent will not be applied if: intolerance or allergy against Gadolinium contrast agents; denial of the Patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Agreement of Areas of arrhythmogenic substrate as determined by electroanatomical substrate mapping (reference) vs. periprocedural LGE-MRI. | — |
Secondary
| Measure | Time frame |
|---|---|
| Agreement regarding identification of atrial scar (incl. localisation) between periprocedural 2D-strain echocardiography, periprocedural LGE-MRI and invasive electroanatomical mapping. | — |
Countries
Germany
Contacts
Public ContactTill Althoff
Charité - Universitätsmedizin Berlin, Klinik für Kardiologie und Angiologie, Charité Campus Mitte
Outcome results
None listed